Tell us about your biggest client wins this year. In 2018, [my] efforts, combined with those of [my] co-lead counsel, in In re Lidoderm Antitrust (N.D. Cal.) resulted in certification of a class of end-payor plaintiffs.

Shortly before jury selection was set to begin, [my] co-leads [and I] secured settlements totaling $104.75 million—one of the largest recoveries by end payors in a federal generic suppression case in more than a decade.